Eli Lilly to acquire Alnara Pharmaceuticals

Friday 2 July 2010

Eli Lilly announced that it has reached an agreement to acquire the privately-held US biotechnology company, Alnara Pharmaceuticals Inc which is developing protein therapeutics for metabolic diseases. Financial terms were not disclosed.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States